ARCHIV AKCÍ ČTS (2005 – 2014)
Krátký | Transplant Academy |
Název akce | The 2nd Transplant Academy: Post-transplant Immunosuppression 2005 |
Místo | Marriott Hotel |
Město | Praha1, V Celnici 8 |
Země | Česká Republika |
Od | 2005-11-17 |
Do | 2005-11-17 |
Orginfo | Pozvánku včetně programu naleznete ve formátu pdf.OrganizátořiČTSThe Middle-East Society of Organ Transplantation Programový koordinátořiS. Vítko (Prague), M. Masri (Beirut)Organizační výborO. ViklickýP. Trunečka E. Pokorná F. Saudek M. Adamec M. Oliverius SponzorIVAX Pharmaceuticals |
Program | 7:30-8:30 Registration 8:30-8:40 S. Vítko (Prague, Czech Rebublic) Welcome and Opening Remarks Session 1:8:40-9:10 J.M.Cecka (Los Angeles, California)Organ Transplantation World-wide 9:15-9:45 F.A.M. Shaheen (Riyadh, Saudi Arabia) Transplant Issues in Middle East Countries 9:50-10:20 H.M. Sayegh (Boston, Massachusetts) Overview of Transplant Immunobiology 10:25-10:55 F. Vincenti (San Francisco, California) Antibody Induction Therapy 10:55-11:25 Coffee break Session 211:25-11:55 M.Haberal (Ankara, Turkey)Immunosuppressive Strategies in Highly Immunized Patients 12:00-12:30 P. Terasaki (Los Angeles, California) Pathology of Acute and "Chronic" Rejection, Antibody-Mediated Rejection 12:35-13:05 S. Vítko (Prague, Czech Rebublic) Steroid Withdrawal and/or Immunosuppression Without Steroids 13:10-14:10 Lunch at Marriott Hotel Session 314:10-14:40 O. Viklický (Prague, Czech Rebublic)Current Role of Calcineurin Inhibitors 14:45-15:15 D. Hricik (Cleveland, Ohio) Efficacy and Side-Effects of mTORs Based Regimens 15:20-15:50 L. Paczek (Warsaw, Poland) Role of Antimetabolites in the Immunosuppressive Regimens 15:55-16:25 Coffee break Session 416:25-16:55 S. Rizk (Beirut, Lebanon)Monitoring of Immunosuppressive Therapy 17:00-17:30 M.Masri (Beirut, Lebanon) Generics - FDA Rules and Regulations 17:35-18:05 M. H. Sayegh (Boston, Massachusetts) Current Status and Future of Tolerance 18:10-18:30 F. Vincenti (San Francisco, California) Summary and Closing Remarks 18:30 Course Adjourns |
Spol | 1 |